<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of autoantibodies detected by their effects on <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-dependent coagulation assays </plain></SENT>
<SENT sid="1" pm="."><plain>Persistent <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> are associated with <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombotic disease</z:e>, but not <z:hpo ids='HP_0000001'>all</z:hpo> are clinically significant </plain></SENT>
<SENT sid="2" pm="."><plain>Antibody <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> and reagent and test variability dictate that at least 2 tests, of different types, should be used to screen <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The objective of this study was to investigate whether the activated seven <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> assay detects clinically significant antibodies </plain></SENT>
<SENT sid="4" pm="."><plain>Eighty-two patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) and 32 with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> + positive for activated seven <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and who were without <z:mp ids='MP_0005048'>thrombosis</z:mp>, who were positive by activated seven <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> assay, were investigated for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> by dilute Russell's viper venom time, dilute activated partial thromboplastin time, and Taipan snake venom time, and for anticardiolipin antibodies </plain></SENT>
<SENT sid="5" pm="."><plain>Fifty-seven of the APS patients were positive for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> in multiple assays, 25 in activated seven <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> alone </plain></SENT>
<SENT sid="6" pm="."><plain>Fourteen of the latter group were previously positive in other <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> assays, and 11 had only been positive for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> by activated seven <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Twenty-eight had elevated anticardiolipin antibodies, 6 of whom were from the group that was positive in activated seven <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> only </plain></SENT>
<SENT sid="8" pm="."><plain>Eight of the <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> + <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> (without <z:mp ids='MP_0005048'>thrombosis</z:mp>) patients were positive for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> by activated seven <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> alone and had only been positive in activated seven <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> previously, and none had elevated anticardiolipin antibodies </plain></SENT>
<SENT sid="9" pm="."><plain>The remaining 24 patients were <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-<z:chebi fb="3" ids="50249">anticoagulant</z:chebi> positive in multiple assays, and 9 had elevated anticardiolipin antibodies </plain></SENT>
<SENT sid="10" pm="."><plain>Dilute Russell's viper venom time and Dilute activated partial thromboplastin time are widely used to detect <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> and are considered to detect clinically significant antibodies </plain></SENT>
<SENT sid="11" pm="."><plain>Activated seven <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> detected antibodies in APS patients who were positive by these assays and also <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> undetectable by the dilute Russell's viper venom time/dilute activated partial thromboplastin time reagents used, demonstrating its utility as a first-line or second-line assay </plain></SENT>
</text></document>